Paul M Ridker, MD, MPH
Paul M Ridker, MD, MPH
Eugene Braunwald Professor of Medicine, Harvard Medical School
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
Inflammation and atherosclerosis
P Libby, PM Ridker, A Maseri
Circulation 105 (9), 1135-1143, 2002
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists' Collaboration
Bmj 324 (7329), 71-86, 2002
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ...
New England journal of medicine 359 (21), 2195-2207, 2008
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker, CH Hennekens, JE Buring, N Rifai
New England journal of medicine 342 (12), 836-843, 2000
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens
New England journal of medicine 336 (14), 973-979, 1997
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan, JAE Manson, N Rifai, JE Buring, PM Ridker
Jama 286 (3), 327-334, 2001
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
PM Ridker, N Rifai, L Rose, JE Buring, NR Cook
New England journal of medicine 347 (20), 1557-1565, 2002
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ...
Circulation 108 (14), 1664-1672, 2003
Progress and challenges in translating the biology of atherosclerosis
P Libby, PM Ridker, GK Hansson
Nature 473 (7347), 317-325, 2011
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists
The Lancet 376 (9753), 1670-1681, 2010
Biological, clinical and population relevance of 95 loci for blood lipids
TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ...
Nature 466 (7307), 707-713, 2010
Long-term effects of pravastatin on plasma concentration of C-reactive protein
PM Ridker, N Rifai, MA Pfeffer, F Sacks, E Braunwald
Circulation 100 (3), 230-235, 1999
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
Circulation 107 (3), 363-369, 2003
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ...
Nature genetics 42 (11), 937-948, 2010
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women
PM Ridker, JE Buring, NR Cook, N Rifai
Circulation 107 (3), 391-397, 2003
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker, N Rifai, MJ Stampfer, CH Hennekens
Circulation 101 (15), 1767-1772, 2000
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L KÝber, ...
New England Journal of Medicine 349 (20), 1893-1906, 2003
The system can't perform the operation now. Try again later.
Articles 1–20